🔎 Trials Near Me

Gara Jalqabaatti › Psoriasis › Pennsylvania

Qorannoo klinikaalii Psoriasis Pennsylvania keessatti

Qorannoo 6 Psoriasis f Pennsylvania keessatti hirmaatuu jiru.

Magaalota Pennsylvania keessatti

Takkalaa qorannoo (Ingiliffa)

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • UPMC Hillman Cancer Center, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT03816345

A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis

  • LEO Pharma Investigational Site, Philadelphia
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07013201

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

  • Dermatology Associates of Plymouth Meeting, Plymouth Meeting
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT06857942

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

  • Paddington Testing Company, Philadelphia
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 hanga 17 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06979453

A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis

  • Study Center, Philadelphia
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 09-Ado-2026 · NCT07489885

Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques

  • Temple University, Philadelphia
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ama-2025 · NCT05642182

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.